# K113841: Immunocap Allergen Components Bundle

- Pathway: 510(k) (Traditional)
- Applicant: Phadia US, Inc.
- Decided: Sep 13, 2012 after 260 days
- Product code: DHB (System, Test, Radioallergosorbent (Rast) Immunological)
- Device class: 2
- Regulation: 21 CFR 866.5750
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 2 generations back to K894190 (1990). 5 ancestors in all.
1 later device descends from it; 1 cites it directly.
0 of 7 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K051218: Modification to:  Unicap Specific Ige, Pharmacia Diagnostics AB (2005)
- K962274: Unicap 100, Pharmacia, Inc. (1996) Summary page 2.
- K991048: Allergen Immunocap, Models E7, F93, F94, F95, F203, F204, F208, F209, F210, F214, F216, F235, F237, F242, F255, F259, F2, Pharmacia & Upjohn Co. (1999) Summary page 2.

## Most influential descendants
- K151029: Phadia Prime (2016), 0 descendants of its own

## Indications for use
ImmunoCAP Specific IgE is an in vitro quantitative assay for the measurement of allergen specific IgE in human serum or plasma (EDTA or Na-Heparin). ImmunoCAP Specific IgE is to be used with instruments Phadia 100, Phadia 250, and Phadia 1000. It is intended for in vitro diagnostic use as an aid in the clinical diagnosis of IgE mediated allergic disorders in conjunction with other clinical findings, and is to be used in clinical laboratories.

Source page: https://510kreport.com/device/K113841
Methodology: https://510kreport.com/methodology